Skip to content
healthcare.dev
Get a free key

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

NDC 70748-102, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, tablet, extended release, from Lupin Pharmaceuticals, Inc..

Product NDC
70748-102
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211579
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70748-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN5 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70748-102-077074801020760 TABLET, EXTENDED RELEASE in 1 BOTTLE (70748-102-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e6957674-86c1-4536-8e23-54ad7f2cacc4

  • NADAC price for package 70748010207

    GET /v1/drugs/nadac/70748010207

Use it

Look up 70748-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70748-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70748-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.